Joint Formulary & PAD

Anti-D (Rh-) immunoglobulin - Prevention of Rhesus-D sensitisation

You are here : Home > Formulary Search > Anti-D (Rh-) immunoglobulin - Prevention of Rhesus-D sensitisation

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Injection
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
SPC
Restrictions / Comments :

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Anti-D (Rh-) immunoglobulin
Indication :
Prevention of Rhesus-D sensitisation
Group Name :
Keywords :
Rhesus-D negative, RhD negative, Rhesus disease
Brand Names Include :
Important Information :

SASH - not obtained from Pharmacy.
RSFT / ASPH - available from Pathology

NICE TA156: Routine antenatal anti-D prophylaxis for women who are rhesus D negative

BSOH guideline-for-the-use-of-anti-d-immunoglobulin-for-the-prevention-of-haemolytic-disease-of-the-fetus-and-newborn
 

Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Committee Recommendations (0)

  • No records returned.

Other Indications

Below are listed other indications that Anti-D (Rh-) immunoglobulin is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat Prevention of Rhesus-D sensitisation.

  • No records returned.